Skip to content

A comparative study between phaltrikadi Kashaya & phaltrikadi Kashaya Ghana vati in the management of non alcoholic fatty liver disease

A clinical study to evaluate the comparative efficacy of phaltrikadi Kashaya and phaltrikadi Kashaya Ghana vati in the management of non alcoholic fatty liver disease - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/08/056191
Enrollment
50
Registered
2023-08-07
Start date
Unknown
Completion date
Unknown
Last updated
2023-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K760- Fatty (change of) liver, not elsewhere classified

Interventions

None listed

Sponsors

Rajiv Gandhi Govt Post Graduate Ayurvedic College and hospital Paprola
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Altered serum liver enzymes- AST and/or ALT >normal (35-40U/L) - <2times of upper normal limit

Exclusion criteria

Exclusion criteria: Patients consuming alcohol Patients having Hepatitis B/ Hepatitis C, malignancy of liver USG evidence of cirrhosis or necrosis of liver

Design outcomes

Primary

MeasureTime frame
A clinical study to evaluate the comparative efficacy of phaltrikadi Kashaya and phaltrikadi Kashaya Ghana vati in the management of non alcoholic fatty liver diseaseTimepoint: 12 weeks

Secondary

MeasureTime frame
To assess the clinical safety of phaltrikadi Kashaya & phaltrikadi Kashaya Ghana vati in the management of non alcoholic fatty liver diseaseTimepoint: 12 weeks

Countries

India

Contacts

Public ContactDr Mehak Chaudhary

Rajiv Gandhi Govt Post Graduate Ayurvedic College and Hospital

drmsony@gmail.com9816842425

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026